临床外科杂志
臨床外科雜誌
림상외과잡지
JOURNAL OF CLINICAL SURGERY
2014年
9期
663-665
,共3页
曾天才%蔡庆和%徐阳%张林菲%周晋航%涂华华%陈先祥
曾天纔%蔡慶和%徐暘%張林菲%週晉航%塗華華%陳先祥
증천재%채경화%서양%장림비%주진항%도화화%진선상
PEP-1肽%血红素加氧酶-1%肝细胞%缺氧复氧%保护
PEP-1肽%血紅素加氧酶-1%肝細胞%缺氧複氧%保護
PEP-1태%혈홍소가양매-1%간세포%결양복양%보호
PEP-1 peptide%Heme Oxygenase-1%hepatocytehy poxia-rexygenation%protective
目的:评价细胞穿透肽PEP-1介导血红素加氧酶-1(HO-1)预处理对L02肝细胞缺氧复氧损伤的影响。方法利用基因工程手段表达和纯化融合蛋白PEP-1-HO-1(PEP-1-heme oxy-genase-1,PEP-1-HO-1)。使用人肝细胞株(HL-7702)建立培养人肝细胞缺氧复氧模型。按实验需要以10%新生牛血清的DMEM液静置培养L02肝细胞,将细胞进行随机分为7组:A组,正常对照组(常规培养);B组,缺氧复氧组(缺氧复氧组细胞缺氧18 h,复氧6 h);C组,PEP-1-HO-1预处理组,按PEP-1-HO-1浓度分为5亚组(C1,0.125μmol/L;C2,0.25μmol/L ;C3,0.5μmol/L;C4,1.0μmol/L;C5,2.0μmol/L,缺氧前以PEP-1-HO-1融合蛋白预处理2 h,缺氧18 h,复氧6 h)。复氧结束后,收集各组细胞及培养液上清,检测MDA、LDH、AST、ALT含量及SOD活性。结果缺氧复氧组较正常对照组相比,MDA、LDH、AST及ALT水平明显升高(P<0.05),而 SOD 水平下降(P<0.05);PEP-1-HO-1预处理组与缺氧复氧组相比,预处理组能明显降低MDA、LDH、AST及ALT水平(P<0.05),使得SOD水平上升(P<0.05),且在一定浓度下与剂量呈正相关。结论 PEP-1-HO-1融合蛋白预处理可减轻细胞缺氧复氧损伤。
目的:評價細胞穿透肽PEP-1介導血紅素加氧酶-1(HO-1)預處理對L02肝細胞缺氧複氧損傷的影響。方法利用基因工程手段錶達和純化融閤蛋白PEP-1-HO-1(PEP-1-heme oxy-genase-1,PEP-1-HO-1)。使用人肝細胞株(HL-7702)建立培養人肝細胞缺氧複氧模型。按實驗需要以10%新生牛血清的DMEM液靜置培養L02肝細胞,將細胞進行隨機分為7組:A組,正常對照組(常規培養);B組,缺氧複氧組(缺氧複氧組細胞缺氧18 h,複氧6 h);C組,PEP-1-HO-1預處理組,按PEP-1-HO-1濃度分為5亞組(C1,0.125μmol/L;C2,0.25μmol/L ;C3,0.5μmol/L;C4,1.0μmol/L;C5,2.0μmol/L,缺氧前以PEP-1-HO-1融閤蛋白預處理2 h,缺氧18 h,複氧6 h)。複氧結束後,收集各組細胞及培養液上清,檢測MDA、LDH、AST、ALT含量及SOD活性。結果缺氧複氧組較正常對照組相比,MDA、LDH、AST及ALT水平明顯升高(P<0.05),而 SOD 水平下降(P<0.05);PEP-1-HO-1預處理組與缺氧複氧組相比,預處理組能明顯降低MDA、LDH、AST及ALT水平(P<0.05),使得SOD水平上升(P<0.05),且在一定濃度下與劑量呈正相關。結論 PEP-1-HO-1融閤蛋白預處理可減輕細胞缺氧複氧損傷。
목적:평개세포천투태PEP-1개도혈홍소가양매-1(HO-1)예처리대L02간세포결양복양손상적영향。방법이용기인공정수단표체화순화융합단백PEP-1-HO-1(PEP-1-heme oxy-genase-1,PEP-1-HO-1)。사용인간세포주(HL-7702)건립배양인간세포결양복양모형。안실험수요이10%신생우혈청적DMEM액정치배양L02간세포,장세포진행수궤분위7조:A조,정상대조조(상규배양);B조,결양복양조(결양복양조세포결양18 h,복양6 h);C조,PEP-1-HO-1예처리조,안PEP-1-HO-1농도분위5아조(C1,0.125μmol/L;C2,0.25μmol/L ;C3,0.5μmol/L;C4,1.0μmol/L;C5,2.0μmol/L,결양전이PEP-1-HO-1융합단백예처리2 h,결양18 h,복양6 h)。복양결속후,수집각조세포급배양액상청,검측MDA、LDH、AST、ALT함량급SOD활성。결과결양복양조교정상대조조상비,MDA、LDH、AST급ALT수평명현승고(P<0.05),이 SOD 수평하강(P<0.05);PEP-1-HO-1예처리조여결양복양조상비,예처리조능명현강저MDA、LDH、AST급ALT수평(P<0.05),사득SOD수평상승(P<0.05),차재일정농도하여제량정정상관。결론 PEP-1-HO-1융합단백예처리가감경세포결양복양손상。
Objective To evaluate the pretreatment effects of heme oxygenase-1 mediated by cell-penetrating peptide PEP-1 on cultured human hepatocytes(L02)against hypoxia-reoxygenation injury. Methods Genetic engineering techniques were used to express and purify PEP-1-heme oxygenase-1 (PEP-1-HO-1)fusion protein.Human hepatic cell line(HL-7702)was used to establish the model of he-patic hypoxia-reoxygenation injury.According to the experimental requirement,L02 cells were fed with Dulbecco's modified Eagle Medium supplemented with the 10%fetal bovine serum.The cultured L02 cells were divided into 7 groups randomly.Group A(CTL)received no anoxia and served as control and Group B (H/R)received 18 hours of anoxia,followed by reoxygenation for 6 hours.According to the concentration of PEP-1-HO-1 pretreatment,Group C were divided into 5 subgroups,including Group C1 (0.125 μmol/L),Group C2(0.25 μmol/L),Group C3(0.5 μmol/L),Group C4(1.0 μmol/L)and Group C5(2.0μmol/L).PEP-1-HO-1 fusion protein was pretreated for 2 hours before 18 hours of hypoxia and 6 hours of reoxygenation.The contents of ALT,AST,LDH,MDA and SOD viability in the culture medium were col-lected and measured at the end of the experiment.Results Compared with the control group,the level of MDA,LDH,AST and ALT increased and the SOD activity of L02 cells decreased in the H/R group(P<0.05).Compared with the H/R group,the level of MDA,LDH,AST and ALT decreased in the pretreat-ment groups and the SOD activity of L02 cells increased and positively correlated with pretreatment dosage under a certain concentration(P<0.05).Conclusion PEP-1-HO-1 fusion protein pretreatment can pro-tect L02 hepatocytes against hypoxia-rexygenation injury.